APA (7th ed.) Citation

Pravesh Kumar Bundhun, Girish Janoo, Abhishek Rishikesh Teeluck, & Feng Huang. (2017). Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. BMC.

Chicago Style (17th ed.) Citation

Pravesh Kumar Bundhun, Girish Janoo, Abhishek Rishikesh Teeluck, and Feng Huang. Adverse Drug Effects Observed with Vildagliptin Versus Pioglitazone or Rosiglitazone in the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. BMC, 2017.

MLA (9th ed.) Citation

Pravesh Kumar Bundhun, et al. Adverse Drug Effects Observed with Vildagliptin Versus Pioglitazone or Rosiglitazone in the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. BMC, 2017.